RMD vs WTW · P/E 29, rev $5.65B vs P/E 15, rev $4.88B
ResMed Inc (RMD) versus Willis Towers Watson PLC (WTW) — a side-by-side from cached financials, not a winner call.
ResMed Inc (RMD) is a medical instruments & supplies company listed on US.
Willis Towers Watson PLC (WTW) is a insurance brokers company listed on NASDAQ.
Latest reported RMD revenue for 2026-06-30 was $5.65B. Net income was $1.52B. Revenue was up 9.9% from 2025-06-30 to 2026-06-30. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
Latest reported WTW revenue for 2026-06-30 was $4.88B. Net income was $526.0M. WTW currently screens at market cap $24.41B and trailing P/E 15.2.
RMD currently screens at market cap $37.68B and trailing P/E 28.8. WTW currently screens at market cap $24.41B and trailing P/E 15.2.
Not investment advice. Open the RMD and WTW stock pages for the full models.
Not investment advice.